Transforming Growth Factor-beta 1 and Follistatin in Patients with Hepatocellular Carcinoma and Patients with Liver Cirrhosis
Dina Morsy Ahmed Mohamed;
Abstract
The incidence of hepatocellular carcinoma (HCC) is increasing worldwide with cirrhosis being the strongest risk factor for the development of HCC.
Although HCC screening with AFP and ultrasonography has been recommended for persons with cirrhosis, its le
Although HCC screening with AFP and ultrasonography has been recommended for persons with cirrhosis, its le
Other data
| Title | Transforming Growth Factor-beta 1 and Follistatin in Patients with Hepatocellular Carcinoma and Patients with Liver Cirrhosis | Other Titles | دراسة أهمية عامل تحول النمو بيتا واحد و الفوليستاتين في مرضي التليف الكبدي في حاله وجود | Authors | Dina Morsy Ahmed Mohamed | Keywords | Transforming Growth Factor-beta 1 and Follistatin in Patients with Hepatocellular Carcinoma and Patients with Liver Cirrhosis | Issue Date | 2012 | Description | The incidence of hepatocellular carcinoma (HCC) is increasing worldwide with cirrhosis being the strongest risk factor for the development of HCC. Although HCC screening with AFP and ultrasonography has been recommended for persons with cirrhosis, its le |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 118869A5393.pdf | 365.66 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.